Vitamins & Minerals Supplements Market Research Report Forecast to 2030

The vitamins & Minerals Supplement Market is anticipated to register a healthy CAGR of 6.57 % during the review period. The key elements driving the developing demand for insusceptibility helping products and expanding medical services costs are a portion of the essential variables adding to its market development.

The rising demand for resistance-supporting products is marked by the heightened deals and new product dispatches by a portion of the makers in the market. According to MRFR examination, the deals of vitamin and mineral supplements have witnessed a development of around 16% in 2021 compared to 2020 in the US region. In 2021, Normal Food Merchants, one of the staple chain portions of Vitamin Cabin, Inc. in the United States has launched a scope of vitamins and supplements under its brand. As a component of the send-off, the organization has likewise rolled out a one-on-one virtual meeting with a dietary well-being mentor who would help in educating the clients regarding the vitamins and supplements product free of cost. Around the same time, Bassetts Vitamins launched another scope of vitamin products that are targeted at the adult fragment involving pregnant ladies, people, and elderly individuals. The organization representative in a public statement of the product mentioned that shoppers are confronting difficulties in choosing the right vitamin supplement product that takes care of the intended age gathering and necessity and subsequently has launched the new reach with clear demarcation that can be effortlessly identified.

Market Segmentation

The Vitamins & Minerals Supplement Market segmentation, based on the product type, includes vitamins and minerals.

The Vitamins & Minerals Supplement Market form data has been bifurcated into powder, capsule & tablets, liquid, and others. Based on form, the market is segmented into men, women, and children.

Regional Analysis

The Asia-Pacific region has turned into a critical player in the global vitamins and minerals market, and the trend towards better utilization propensities is proceeding to develop. India, China, Japan, and Australia and New Zealand are the significant nations that have been considered for the examination of the Asia-Pacific vitamin and mineral supplement market.

The Europe vitamins and minerals supplements market is second of the biggest regions in the global vitamins and minerals supplements market. Europe is probably going to uphold a significant offer in the market for vitamin and mineral supplements, this is chiefly due to the presence of a couple of the central participants having tasks across the globe in the region followed by a few procedures for the development and development adopted by them to keep up with their hold in the regional market. Besides, vitamin and mineral supplements have gained greater notoriety in the European market as the region has a rising number of working populaces.

Major Players

Key Companies in the Vitamins & Minerals Supplement market include Bayer AG (Germany), Glanbia Plc (Ireland), Abbott (US), Pfizer, Inc (US), Amway Corp (US), GSK Plc. (UK), Herbalife International of America, Inc. (US), Otsuka Pharmaceutical Co., Ltd. (Japan), Nature's Way Brands (US), and Nature's Bounty (US).

Product Code: MRFR/F-B & N/10452-CR

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 17

1.1 GLOBAL VITAMIN & MINERAL SUPPLEMENTS MARKET, BY TYPE 20
1.2 GLOBAL VITAMIN & MINERAL SUPPLEMENTS MARKET, BY FORM 21
1.3 GLOBAL VITAMIN & MINERAL SUPPLEMENTS MARKET, BY END-USER 22
1.4 GLOBAL VITAMIN & MINERAL SUPPLEMENTS MARKET, BY APPLICATION 23
1.5 GLOBAL VITAMIN & MINERAL SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL 24
1.6 GLOBAL VITAMIN & MINERAL SUPPLEMENTS MARKET, BY REGION 25

2 MARKET INTRODUCTION 26

2.1 DEFINITION 26
2.2 SCOPE OF THE STUDY 26
2.3 RESEARCH OBJECTIVE 26
2.4 MARKET STRUCTURE 27

3 RESEARCH METHODOLOGY 28

3.1 RESEARCH PROCESS 28
3.2 PRIMARY RESEARCH 29
3.3 SECONDARY RESEARCH 30
3.4 MARKET SIZE ESTIMATION 31
3.5 FORECAST MODEL 32
3.6 LIST OF ASSUMPTIONS & LIMITATIONS 33

4 MARKET DYNAMICS 34

4.1 INTRODUCTION 34
4.2 DRIVERS 35
- 4.2.1 GROWING DEMAND FOR IMMUNITY-BOOSTING PRODUCTS 35
- 4.2.2 US GYM MEMBERSHIP BY GENERATION, 2021 35
- 4.2.3 INCREASING HEALTHCARE COSTS 36
- 4.2.4 DRIVERS IMPACT ANALYSIS 37
4.3 RESTRAINT 37
- 4.3.1 RISE OF COUNTERFEIT AND FAKE PRODUCTS SUPPLY 37
- 4.3.2 RESTRAINT IMPACT ANALYSIS 38
4.4 OPPORTUNITIES 38
- 4.4.1 STRONG GROWTH OF THE GERIATRIC POPULATION 38
- 4.4.2 GROWTH OF E-COMMERCE SALES IN THE DIETARY SUPPLEMENTS INDUSTRY 39
4.5 CHALLENGES 40
- 4.5.1 VARYING GOVERNMENT REGULATIONS RELATED TO LABELING AND CLAIMS 40

5 MARKET FACTOR ANALYSIS 41

5.1 VALUE CHAIN ANALYSIS 41
- 5.1.1 RAW MATERIAL PROCUREMENT 42
- 5.1.2 PROCESSING 42
- 5.1.3 PACKING 42
5.2 SUPPLY CHAIN ANALYSIS 43
- 5.2.1 RAW MATERIAL SOURCING 44
- 5.2.2 MANUFACTURING 44
- 5.2.3 DISTRIBUTION 44
- 5.2.4 END-USER 44
5.3 PORTER'S FIVE FORCES MODEL 45
- 5.3.1 THREAT OF NEW ENTRANTS 45
- 5.3.2 BARGAINING POWER OF SUPPLIERS 46
- 5.3.3 THREAT OF SUBSTITUTES 46
- 5.3.4 BARGAINING POWER OF BUYERS 46
- 5.3.5 INTENSITY OF RIVALRY 46
5.4 IMPACT OF COVID-19 ON THE GLOBAL VITAMIN AND MINERAL SUPPLEMENTS MARKET 47
- 5.4.1 IMPACT ON RAW MATERIAL AVAILABILITY & PRODUCTION 47
- 5.4.2 IMPACT ON CONSUMER BUYING BEHAVIOUR 48
- 5.4.3 IMPACT ON ONLINE VS STORE-BASED SALES 48
- 5.4.4 IMPACT ON PRICING 48

6 GLOBAL VITAMIN & MINERAL SUPPLEMENTS MARKET, BY TYPE 49

6.1 OVERVIEW 49
- 6.1.1 GLOBAL VITAMIN & MINERAL SUPPLEMENTS MARKET ESTIMATES & FORECAST, BY TYPE, 2020-2030 50
6.2 VITAMINS 51
- 6.2.1 VITAMINS: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 52
6.3 MINERALS 52
- 6.3.1 MINERALS: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 53

7 GLOBAL VITAMIN & MINERAL SUPPLEMENTS MARKET, BY FORM 54

7.1 OVERVIEW 54
- 7.1.1 GLOBAL VITAMIN & MINERAL SUPPLEMENTS MARKET ESTIMATES & FORECAST, BY FORM, 2020-2030 55
7.2 POWDER 55
- 7.2.1 POWDER: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 55
7.3 CAPSULE & TABLETS 56
- 7.3.1 CAPSULE & TABLETS: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 56
7.4 LIQUID 57
- 7.4.1 LIQUID: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 57
7.5 OTHERS 58
- 7.5.1 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 58

8 GLOBAL VITAMIN & MINERAL SUPPLEMENTS MARKET, BY END USER 59

8.1 OVERVIEW 59
- 8.1.1 GLOBAL VITAMIN & MINERAL SUPPLEMENTS MARKET ESTIMATES & FORECAST, BY END USER, 2020-2030 60
8.2 MEN 60
- 8.2.1 MEN: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 60
8.3 WOMEN 61
- 8.3.1 WOMEN: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 61
8.4 UNISEX 62
- 8.4.1 UNISEX: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 62

9 GLOBAL VITAMIN & MINERAL SUPPLEMENTS MARKET, BY APPLICATION 63

9.1 OVERVIEW 63
- 9.1.1 GLOBAL VITAMIN & MINERAL SUPPLEMENTS MARKET ESTIMATES & FORECAST, BY APPLICATION, 2020-2030 64
9.2 ENERGY/SPORTS NUTRITION 65
- 9.2.1 ENERGY/ SPORTS NUTRITION: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 65
9.3 WEIGHT MANAGEMENT 66
- 9.3.1 WEIGHT MANAGEMENT: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 66
9.4 IMMUNITY AND DIGESTIVE HEALTH 67
- 9.4.1 IMMUNITY AND DIGESTIVE HEALTH: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 67
9.5 ANTI-CANCER 68
- 9.5.1 ANTI-CANCER: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 68
9.6 SKIN CARE 69
- 9.6.1 SKIN CARE: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 69
9.7 GLYCEMIC & DIABETES MANAGEMENT 70
- 9.7.1 GLYCEMIC & DIABETES MANAGEMENT: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 70
9.8 OTHER 71
- 9.8.1 OTHER: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 71

10 GLOBAL VITAMIN & MINERAL SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL 72

10.1 OVERVIEW 72
- 10.1.1 GLOBAL VITAMIN & MINERAL SUPPLEMENTS MARKET ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2020-2030 73
10.2 SUPERMARKET & HYPERMARKET 74
- 10.2.1 SUPERMARKET & HYPERMARKET: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 74
10.3 CHEMIST/PHARMACIES 75
- 10.3.1 CHEMIST/PHARMACIES: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 75
10.4 DRUGSTORES/PARAPHARAMCIES 76
- 10.4.1 DRUGSTORES/PARAPHARAMCIES: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 76
10.5 ONLINE 77
- 10.5.1 ONLINE: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 77
10.6 OTHERS 78
- 10.6.1 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2020-2030 78

11 GLOBAL VITAMIN & MINERAL SUPPLEMENT MARKET, BY REGION 79

11.1 OVERVIEW 79
11.2 NORTH AMERICA 81
- 11.2.1 US 84
- 11.2.2 CANADA 86
- 11.2.3 MEXICO 88
11.3 EUROPE 90
- 11.3.1 GERMANY 93
- 11.3.2 UK 95
- 11.3.3 FRANCE 97
- 11.3.4 SPAIN 99
- 11.3.5 ITALY 101
- 11.3.6 REST OF EUROPE 103
11.4 ASIA-PACIFIC 106
- 11.4.1 CHINA 109
- 11.4.2 JAPAN 111
- 11.4.3 INDIA 113
- 11.4.4 AUSTRALIA & NEW ZEALAND 115
- 11.4.5 REST OF ASIA-PACIFIC 117
11.5 REST OF THE WORLD 119
- 11.5.1 SOUTH AMERICA 122
- 11.5.2 MIDDLE EAST 124
- 11.5.3 AFRICA 126

12 COMPETITIVE LANDSCAPE 128

12.1 INTRODUCTION 128
12.2 MARKET STRATEGY ANALYSIS 128
12.3 COMPETITIVE BENCHMARKING 129
12.4 KEY DEVELOPMENTS & GROWTH STRATEGIES 131
- 12.4.1 PRODUCT LAUNCH 131
- 12.4.2 EXPANSION 132
- 12.4.3 ACQUISITION 133
- 12.4.4 JOINT VENTURE 133

13 COMPANY PROFILES 134

13.1 BAYER AG 134
- 13.1.1 COMPANY OVERVIEW 134
- 13.1.2 FINANCIAL OVERVIEW 135
- 13.1.3 PRODUCTS OFFERED 135
- 13.1.4 KEY DEVELOPMENTS 136
- 13.1.5 SWOT ANALYSIS 136
- 13.1.6 KEY STRATEGIES 137
13.2 GLANBIA PLC 138
- 13.2.1 COMPANY OVERVIEW 138
- 13.2.2 FINANCIAL OVERVIEW 139
- 13.2.3 PRODUCTS OFFERED 140
- 13.2.4 KEY DEVELOPMENTS 140
- 13.2.5 SWOT ANALYSIS 141
- 13.2.6 KEY STRATEGIES 141
13.3 ABBOTT 142
- 13.3.1 COMPANY OVERVIEW 142
- 13.3.2 FINANCIAL OVERVIEW 143
- 13.3.3 PRODUCTS OFFERED 143
- 13.3.4 KEY DEVELOPMENTS 144
- 13.3.5 SWOT ANALYSIS 145
- 13.3.6 KEY STRATEGIES 145
13.4 PFIZER INC. 146
- 13.4.1 COMPANY OVERVIEW 146
- 13.4.2 FINANCIAL OVERVIEW 146
- 13.4.3 PRODUCTS OFFERED 147
- 13.4.4 KEY DEVELOPMENTS 147
- 13.4.5 SWOT ANALYSIS 148
- 13.4.6 KEY STRATEGIES 148
13.5 AMWAY CORP. 149
- 13.5.1 COMPANY OVERVIEW 149
- 13.5.2 FINANCIAL OVERVIEW 149
- 13.5.3 PRODUCTS OFFERED 150
- 13.5.4 KEY DEVELOPMENTS 150
- 13.5.5 SWOT ANALYSIS 151
- 13.5.6 KEY STRATEGIES 151
13.6 GSK PLC. 152
- 13.6.1 COMPANY OVERVIEW 152
- 13.6.2 FINANCIAL OVERVIEW 153
- 13.6.3 PRODUCTS OFFERED 153
- 13.6.4 KEY DEVELOPMENTS 154
- 13.6.5 KEY STRATEGIES 154
13.7 HERBALIFE INTERNATIONAL OF AMERICA, INC. 155
- 13.7.1 COMPANY OVERVIEW 155
- 13.7.2 FINANCIAL OVERVIEW 156
- 13.7.3 PRODUCTS OFFERED 156
- 13.7.4 KEY DEVELOPMENTS 157
- 13.7.5 KEY STRATEGIES 157
13.8 OTSUKA PHARMACEUTICAL CO., LTD. 158
- 13.8.1 COMPANY OVERVIEW 158
- 13.8.2 FINANCIAL OVERVIEW 158
- 13.8.3 PRODUCTS OFFERED 159
- 13.8.4 KEY DEVELOPMENTS 160
- 13.8.5 KEY STRATEGIES 160
13.9 NATURE'S WAY BRANDS 161
- 13.9.1 COMPANY OVERVIEW 161
- 13.9.2 FINANCIAL OVERVIEW 161
- 13.9.3 PRODUCTS OFFERED 161
- 13.9.4 KEY DEVELOPMENTS 162
- 13.9.5 KEY STRATEGIES 162
13.10 NATURE'S BOUNTY 163
- 13.10.1 COMPANY OVERVIEW 163
- 13.10.2 FINANCIAL OVERVIEW 163
- 13.10.3 PRODUCTS OFFERED 163
- 13.10.4 KEY DEVELOPMENTS 164
- 13.10.5 KEY STRATEGIES 164
13.11 GLOBAL CALCIUM PVT LTD 165
- 13.11.1 COMPANY OVERVIEW 165
- 13.11.2 FINANCIAL OVERVIEW 165
- 13.11.3 PRODUCTS OFFERED 165
- 13.11.4 KEY DEVELOPMENTS 166
- 13.11.5 SWOT ANALYSIS 166
- 13.11.6 KEY STRATEGIES 166
13.12 LEHMANN&VOSS&CO. (LEHVOSS) 167
- 13.12.1 COMPANY OVERVIEW 167
- 13.12.2 FINANCIAL OVERVIEW 167
- 13.12.3 PRODUCTS OFFERED 167
- 13.12.4 KEY DEVELOPMENTS 168
- 13.12.5 SWOT ANALYSIS 169
- 13.12.6 KEY STRATEGIES 169
13.13 ZINPRO CORP. 170
- 13.13.1 COMPANY OVERVIEW 170
- 13.13.2 FINANCIAL OVERVIEW 170
- 13.13.3 PRODUCTS OFFERED 170
- 13.13.4 KEY DEVELOPMENTS 171
- 13.13.5 SWOT ANALYSIS 171
- 13.13.6 KEY STRATEGIES 171
13.14 NOVOTECH NUTRACEUTICALS, INC. 172
- 13.14.1 COMPANY OVERVIEW 172
- 13.14.2 FINANCIAL OVERVIEW 172
- 13.14.3 PRODUCTS OFFERED 172
- 13.14.4 KEY DEVELOPMENTS 172
- 13.14.5 SWOT ANALYSIS 173
- 13.14.6 KEY STRATEGIES 173
13.15 AMERICA ALIMENTOS SA DE CV 174
- 13.15.1 COMPANY OVERVIEW 174
- 13.15.2 FINANCIAL OVERVIEW 174
- 13.15.3 PRODUCTS OFFERED 174
- 13.15.4 KEY DEVELOPMENTS 174
- 13.15.5 SWOT ANALYSIS 175
- 13.15.6 KEY STRATEGIES 175
13.16 JOST CHEMICAL CO. 176
- 13.16.1 COMPANY OVERVIEW 176
- 13.16.2 FINANCIAL OVERVIEW 176
- 13.16.3 PRODUCTS OFFERED 176
- 13.16.4 KEY DEVELOPMENTS 177
- 13.16.5 KEY STRATEGIES 177

14 APPENDIX 178

14.1 REFERENCES 178
14.2 RELATED REPORTS 178